Pantheon Investment Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$683K Sell
22,205
-1,631
-7% -$53.1K 0.54% 56
2021
Q3
$792K Sell
23,836
-581
-2% -$18.6K 0.68% 53
2021
Q2
$739K Buy
+24,417
New +$804K 0.62% 55

Other funds holding OGN

Pantheon Investment Group's OGN Position: Q4 2021 in Review

Pantheon Investment Group reduced its Organon & Co (OGN) stake by 6.8% in Q4 2021, selling an estimated $53.1K and leaving 22,205 shares worth $683K. The position accounts for 0.54% of the portfolio, ranked #56.

Pantheon Investment Group first reported a position in OGN in Q2 2021 and has held it in 3 quarters since. The position peaked at $792K in Q3 2021. 907 funds tracked by Wall St. Rank hold OGN as of Q4 2021.

  • Pantheon Investment Group held 22,205 shares of Organon & Co worth $683K as of Q4 2021.
  • Pantheon Investment Group sold 1,631 Organon & Co shares in Q4 2021, an estimated $53.1K.
  • Organon & Co made up 0.54% of Pantheon Investment Group's portfolio in Q4 2021, its #56 holding.
  • Pantheon Investment Group first reported a position in Organon & Co in Q2 2021 and has held it in 3 quarters since.
  • Pantheon Investment Group's Organon & Co position peaked at $792K in Q3 2021.
  • 907 funds tracked by Wall St. Rank held Organon & Co as of Q4 2021.

Based on Pantheon Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.